BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32441484)

  • 21. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
    Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
    Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low expression of NCALD is associated with chemotherapy resistance and poor prognosis in epithelial ovarian cancer.
    Feng LY; Li L
    J Ovarian Res; 2020 Mar; 13(1):35. PubMed ID: 32228639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of Prognostic Marker Genes by Public Microarray Data in Patients with Ovarian Serous Cystadenocarcinoma.
    Yang SD; Jang SS; Han JA; Park HS; Kim JI
    Yonsei Med J; 2016 Jul; 57(4):872-8. PubMed ID: 27189279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of chemotherapy response programs in ovarian cancers by the next-generation sequencing technologies.
    Cheng L; Lu W; Kulkarni B; Pejovic T; Yan X; Chiang JH; Hood L; Odunsi K; Lin B
    Gynecol Oncol; 2010 May; 117(2):159-69. PubMed ID: 20181382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptome analysis identifies the differentially expressed genes related to the stemness of limbal stem cells in mice.
    Guo ZH; Jia YYS; Zeng YM; Li ZF; Lin JS
    Gene; 2021 Apr; 775():145447. PubMed ID: 33482278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploration of the sequential gene changes in epithelial ovarian cancer induced by carboplatin via microarray analysis.
    Wei S; Liu J; Shi Y; Zhang X; Yang Y; Song Q
    Mol Med Rep; 2017 Sep; 16(3):3155-3160. PubMed ID: 28713952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening the molecular targets of ovarian cancer based on bioinformatics analysis.
    Du L; Qian X; Dai C; Wang L; Huang D; Wang S; Shen X
    Tumori; 2015; 101(4):384-9. PubMed ID: 25953442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profile analysis in response to α1,2-fucosyl transferase (FUT1) gene transfection in epithelial ovarian carcinoma cells.
    Gao S; Zhu L; Feng H; Hu Z; Jin S; Song Z; Liu D; Liu J; Hao Y; Li X; Lin B
    Tumour Biol; 2016 Sep; 37(9):12251-12262. PubMed ID: 27240592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Key Genes and Pathway for Ovarian Neoplasms Using the OVDM1 Cell Line Based on Bioinformatics Analysis.
    Yin S; Du J; Zhang J; Zhang X; Ma K
    Med Sci Monit; 2019 Jun; 25():4305-4313. PubMed ID: 31177266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of core genes in ovarian cancer by an integrative meta-analysis.
    Li W; Liu Z; Liang B; Chen S; Zhang X; Tong X; Lou W; Le L; Tang X; Fu F
    J Ovarian Res; 2018 Nov; 11(1):94. PubMed ID: 30453999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
    J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of biomarkers and potential molecular mechanisms of clear cell renal cell carcinoma.
    Wu F; Wu S; Gou X
    Neoplasma; 2018; 65(2):242-252. PubMed ID: 29534586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
    Liang B; Li C; Zhao J
    Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study on the regulatory mechanism and experimental verification of icariin for the treatment of ovarian cancer based on network pharmacology.
    Wang S; Gao J; Li Q; Ming W; Fu Y; Song L; Qin J
    J Ethnopharmacol; 2020 Nov; 262():113189. PubMed ID: 32736044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis.
    Han B; Feng D; Yu X; Zhang Y; Liu Y; Zhou L
    Med Sci Monit; 2018 Aug; 24():6059-6069. PubMed ID: 30168505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.
    Xu Z; Zhou Y; Cao Y; Dinh TL; Wan J; Zhao M
    Med Oncol; 2016 Nov; 33(11):130. PubMed ID: 27757782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptome analysis in primary colorectal cancer tissues from patients with and without liver metastases using next-generation sequencing.
    Wang S; Zhang C; Zhang Z; Qian W; Sun Y; Ji B; Zhang Y; Zhu C; Ji D; Wang Q; Sun Y
    Cancer Med; 2017 Aug; 6(8):1976-1987. PubMed ID: 28745433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioinformatics Analysis of Key Genes and Pathways in Colorectal Cancer.
    Qi Y; Qi H; Liu Z; He P; Li B
    J Comput Biol; 2019 Apr; 26(4):364-375. PubMed ID: 30810359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.